Alterity Therapeutics (ATHE) Profit After Tax (2016 - 2024)

Alterity Therapeutics' Profit After Tax history runs 8 years deep, the most recent figure standing at -$12.8 million for Q2 2024.

• In Q2 2024, Profit After Tax fell 36.64% year-over-year to -$12.8 million; the TTM figure through Jun 2024 stood at -$12.8 million (down 36.64% YoY), while the FY2025 annual figure was -$7.8 million, up 38.27% from the prior year.
• Profit After Tax was -$12.8 million for Q2 2024 at Alterity Therapeutics, down from -$9.3 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of -$6.6 million in Q2 2020 to a low of -$12.8 million in Q2 2024.
• Historically, Profit After Tax has averaged -$9.5 million across 4 years, with a median of -$9.3 million in 2022.
• The sharpest annual moves came in 2020 and 2024: Profit After Tax rose 23.71% in 2020, then tumbled 36.64% in 2024.
• A 4-year view of Profit After Tax shows it stood at -$6.6 million in 2020, then tumbled by 41.44% to -$9.3 million in 2022, then slipped by 0.1% to -$9.3 million in 2023, then sank by 36.64% to -$12.8 million in 2024.
• The last three Profit After Tax figures came in at -$12.8 million (Q2 2024), -$9.3 million (Q2 2023), and -$9.3 million (Q2 2022), per Business Quant data.